Taherifard, Erfan
Bakhtiar, Muhammad
Mahnoor, Mahnoor
Ahmed, Rabeea
Cavalcante, Ludimila
Zhang, Janie
Saeed, Anwaar
Article History
Received: 5 December 2023
Accepted: 27 January 2024
First Online: 12 February 2024
Declarations
:
: Not applicable.
: Not applicable.
: A.S. reports research grants (to institution) from AstraZeneca, Bristol Myers Squibb, Merck, Clovis, Exelixis, Actuate Therapeutics, Incyte Corporation, Daiichi Sankyo, Five Prime Therapeutics, Amgen, Innovent Biologics, Dragonfly Therapeutics, KAHR Medical, and BioNtech and advisory board fees from AstraZeneca, Bristol Myers Squibb, Exelixis, Pfizer, and Daiichi Sankyo. The remaining authors have no relevant financial or non-financial interests to disclose.